Summary Information:
Surmodics Inc. Common Stock
NASDAQ:SRDX


email
admin@troach.net
Our Main Pages
Stocks.TRoach.Net
TRoach.Org
TRoach.Net

NOTE: This page is for evaluation of a JFF Project.
This page is NOT updated on a regular basis.
Information on this page should NOT be used for investment purposes.


Surmodics Inc. Common Stock
Exchange: NASDAQ
Symbol: SRDX
SEC CIK: 0000924717
Phone: 9525007000
9924 W 74TH ST
EDEN PRAIRIE MN 55344

CEO: Gary Maharaj
Price when page updated: 33.73 Date: 2023-12-01
Company Website:
www.surmodics.com

_Description: Surmodics is the global leader in surface modification technologies for intravascular medical devices and a leading provider of chemical components for in vitro diagnostic (IVD) immunoassay tests and microarrays. Surmodics is pursuing highly differentiated medical devices that are designed to address unmet clinical needs and engineered to the most demanding requirements. This key growth strategy leverages the combination of the Company's expertise in proprietary surface technologies, along with enhanced device design, development, and manufacturing capabilities. The Company mission remains to improve the detection and treatment of disease. Surmodics is headquartered in Eden Prairie, Minnesota. For more information, visit www.surmodics.com. The content of Surmodics' website is not part of this press release or part of any filings that the company makes with the SEC.

IPO YEAR:
1998
Sector:
Health Care
Industry:
Biotechnology: Electromedical & Electrotherapeutic Apparatus
ADRTSO:

MarketCap:
477481880.00
Beta:
0.89937029798692
52 Week High:
62.27
52 Week Low:
39.96
52 Week Change:
0.21980495123780952
Short Interest:

Short Date:

Shares Outstanding:
13975286
Dividend Rate:
0
Dividend Yield:
N/A
ExDividend Date:

Latest EPS:

Latest EPS Date:
9 Nov 2022
Float:
0
return on Equity:
-9.60%
Consensus EPS:

Number Of Estimates:

EPS Surprise Dollar:

Eps Surprise Percent:

EBITDA:
-$11.07
ttmEPS:
0.6058
Revenue:
$97.934M
Gross Profit:

Cash:

Debt:

Institution Percent:
92.60%
Revenue Percent:

Revenue Per Employee:

Insider Percent:
2.20%
Return on Assets:
-6.90%
Return on Capital:

Profit Margin:
-13.10%
Price to Sales:
4.87
Price To Book:
3.61
Short Ratio:
10.34
PE Ratio:
80.44777567618598
Employees:
370
1Y Guesstimate
59.209:1.0:6




__The following are links to various summary and news pages for
__Surmodics Inc. Common Stock [ SRDX ].

__Note: Some Links might not have information for the company.


finance.Yahoo.com money.CNN.com NASDAQ research
WalletInvestor.com WSJ.com MarketBeat.com
finviz.com WallMine.com TheGlobeandMail.com
stock1010.com
NASDAQ - General Info SEC Insider Report Ownership Summary
Dividend History insiderbuyingselling.com
Facebook search Twitter search LinkedIn search
PRnewsWire.Com Google Forecast
tdameritrade.com BarChart.com
SeekingAlpha.com Markets.FT.com stocktwits.com
FinTel.io Ldmicro.com bloomberg.com
MarketWatch.com Reuters.com businessinsider.com
fool.com barrons.com zacks.com
GuruFocus.com Investing.com tipranks.com
thestreet.com nytimes.com earningswhispers.com
marketchameleon.com sunshineavenue.com stockinvest.us
stockanalysis.com stockconsultant.com ycharts.com
financialcontent.com docoh.com foxbusiness.com
cnbc.com investorsobserver.com tradingview.com
investopedia.com tmxmoney.com invest.cnyes.com
ask.com bing.com brave.com
duckduckgo.com ecosia.org excite.com
exalead.com gibiru.com hotbot.com
www.info.com infospace.com lycos.com
lukol.com metacrawler.com mojeek.com
becovi.com searx.thegpm.org search.com
swisscows.com webcrawler.com yahoo.com
yandex.com yep.com you.com




INDEX




Page design by: TRoach
Page Last Updated: 2023-12-01